comp_molregno,act_standard_units,act_standard_type,act_activity_comment,act_bao_endpoint,act_type,ass_assay_id,ass_description,ass_assay_type,ass_assay_category,ass_chembl_id,doc_doi,doc_pubmed_id,doc_chembl_id,doc_title,doc_doc_type,doc_abstract,doc_patent_id,coms_canonical_smiles,comp_full_molformula,mold_chembl_id,act_0
409692,nM,ID50,,BAO_0000179,ID50,453354,Antagonist activity at androgen receptor expressed in COS cell by whole cell assay,F,,CHEMBL902508,10.1016/j.bmcl.2006.10.071,17095226,CHEMBL1138416,"Synthesis and SAR of potent and selective androgen receptor antagonists: 5,6-Dichloro-benzimidazole derivatives.",PUBLICATION,"The synthesis and in vivo SAR of 5,6-dichloro-benzimidazole derivatives as novel selective androgen receptor antagonists are described. During screening of 2-alkyl benzimidazoles, it was found that a trifluoromethyl group greatly enhances antagonist activity in the prostate. Benzimidazole 1 is a potent AR antagonist in the rat prostate (ID50 = 0.15 mg/day).",,CC(C)(O)c1nc2cc(Cl)c(Cl)cc2[nH]1,C10H10Cl2N2O,CHEMBL240879,80.0
